- Filed
- Aug 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 121.85M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 122.54M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 124.56M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 123.86M sh |
| Shares Outstanding | Q2 2025 · Jun 30, 2025 | 120.31M sh |
| Shares Outstanding | Q2 2025 · Dec 31, 2024 | 122.18M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $54.3M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $0 |
| Capex | Q2 2025 · Jun 30, 2025 | $734K |
| Capex | Q2 2025 · Jun 30, 2024 | $604K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$54.81M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$57.41M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $24.55M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $115.85M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $249.69M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $495.24M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $792.42M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $784.27M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $814.77M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $802.56M |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | −$796.99M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $786.12M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $240.24M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $289.78M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $321.92M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $307.68M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $448.76M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $762.88M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $1.11B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $1.12B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.10 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.13 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.11 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.16 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.10 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.13 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.11 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.16 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $30.18M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $63.23M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $31.96M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $63.56M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $17.11M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $34.02M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $15.83M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $32.57M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$12.01M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$16.17M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$13.88M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$20.1M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$9.01M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$19.99M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$15.79M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$21.75M |
| Revenue | Q2 2025 · Jun 30, 2025 | $131.89M |
| Revenue | Q2 2025 · Jun 30, 2025 | $265.34M |
| Revenue | Q2 2025 · Jun 30, 2024 | $103.68M |
| Revenue | Q2 2025 · Jun 30, 2024 | $217.78M |